Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Changsha, Hunan, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia

  • Sample Provided: no

    Payment Terms: L/C

    Application: Used as Ensitrelvir (S-217622) Intermediates. We can provide CDMO services for COVID-19 drugs with sufficient capacity. Contact us at sales@huatengusa.com now. 
    ​Ensitrelvir (code name S-217622) is an oral antiviral drug, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It has demonstrated antiviral effectiveness against Delta variant and the recently emerged Omicron variant.

Send your message to this supplier
  • From:
  • To:
    Hunan HuaTeng Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service